Anti-SARS-CoV-2 Neutralizing Antibody Test Kit (ELISA)

Short Description:

This product utilizes an enzyme-linked immunosorbent assay to qualitatively detect any antibodies in serum and plasma that can neutralize the RBD-ACE2 interaction, and this method is not limited by sample species genera and antibody subclasses. Neutralizing antibodies can block the viral spike glycoprotein receptor binding region (RBD) from interacting with the cell surface receptor angiotensin-converting enzyme-2 (ACE2).


Product Detail

Product Tags

Principle

The kit uses the principle of a competition assay to detect neutralizing antibodies against SARS-CoV-2 in serum or plasma samples. First, the sample to be tested, the positive control, and the negative control are mixed with HRP-RBD so that the neutralizing antibody binds to HRP-RBD, and then the mixture is added to a capture plate pre coated with hACE2 protein. HRP-RBD not bound to neutralizing antibody as well as any HRP-RBD bound to non-neutralizing antibody will be captured on the coated plate, while HRP-RBD complex bound to neutralizing antibody is removed during washing. TMB solution was then added to develop color. Finally, stop solution was added and the reaction was terminated. The presence or absence of Anti-SARS-CoV-2 neutralizing antibody in the sample was judged by absorbance (A-value) detection by a microplate reader.

Product Features

High sensitivity, specificity and stability

Product Specification

Principle Enzyme linked immunosorbent assay
Type Competitive method
Certificate CE
Specimen Human serum / plasma
Specification 96T
Storage temperature 2-8℃
Shelf life 12 months

Ordering Information

Product name Pack Specimen
Anti-SARS-CoV-2 Neutralizing Antibody Test Kit (ELISA) 96T Human serum / plasma

  • Previous:
  • Next:

  • Related Products